Literature DB >> 7474088

Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations.

F Berrada1, D Ma, J Michaud, G Doucet, L Giroux, A Kessous-Elbaz.   

Abstract

It is now well documented that human immunodeficiency virus type 1 (HIV-1) induces encephalopathy in patients with AIDS. In vitro studies have implicated the envelope protein (gp120) as a factor which causes neuronal death. To better evaluate the role and elucidate the mechanisms of gp120 neurotoxicity, we have developed transgenic mice carrying a segment of the HIV-1 genome that expresses the viral gp160 protein under the control of the human neurofilament light gene promoter. In two separate lines of transgenic mice, the Env protein was found to be expressed in several nuclei of the brain stem and in the anterior horns of the spinal cord. The two lines showed identical patterns of Env expression. Neuropathological evaluation revealed numerous abnormal dendritic swellings in the immunostained motor neuron structures. Large and numerous neuritic swellings were also prominent in the nucleus gracilis and in the gracilis and cuneate fascicles. In addition, reactive astrocytosis was observed in several immunoreactive areas of the central nervous system. These transgenic mice offer a unique model to further investigate the role of HIV-1 Env protein in neuronal toxicity and to help elucidate the mechanisms that are involved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474088      PMCID: PMC189588     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Functional interaction and partial homology between human immunodeficiency virus and neuroleukin.

Authors:  M R Lee; D D Ho; M E Gurney
Journal:  Science       Date:  1987-08-28       Impact factor: 47.728

2.  Neurologic manifestations of human immunodeficiency virus infection in children.

Authors:  L G Epstein; L R Sharer; J M Oleske; E M Connor; J Goudsmit; L Bagdon; M Robert-Guroff; M R Koenigsberger
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

3.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency.

Authors:  Y M Shen; R R Hirschhorn; W E Mercer; E Surmacz; Y Tsutsui; K J Soprano; R Baserga
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

6.  The AIDS dementia complex: II. Neuropathology.

Authors:  B A Navia; E S Cho; C K Petito; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

7.  Cloning and developmental expression of the murine neurofilament gene family.

Authors:  J P Julien; D Meyer; D Flavell; J Hurst; F Grosveld
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

8.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid.

Authors:  H Hollander; J A Levy
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

View more
  7 in total

Review 1.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 2.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

Review 3.  In vivo modeling of HIV-1 mediated neurodegeneration.

Authors:  E Masliah
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 4.  Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

Authors:  Guido van Marle; Christopher Power
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 5.  Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.

Authors:  Victoria E Thaney; Ana B Sanchez; Jerel A Fields; Arpi Minassian; Jared W Young; Ricky Maung; Marcus Kaul
Journal:  J Neurovirol       Date:  2017-10-26       Impact factor: 2.643

6.  Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder.

Authors:  Félix M Ramos; Manuel Delgado-Vélez; Ángel L Ortiz; Carlos A Báez-Pagán; Orestes Quesada; José A Lasalde-Dominicci
Journal:  J Neurovirol       Date:  2015-11-13       Impact factor: 2.643

7.  Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages.

Authors:  R A Subbramanian; A Kessous-Elbaz; R Lodge; J Forget; X J Yao; D Bergeron; E A Cohen
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.